{"id":73180,"date":"2021-05-20T12:45:00","date_gmt":"2021-05-20T10:45:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=73180"},"modified":"2022-02-28T12:02:25","modified_gmt":"2022-02-28T11:02:25","slug":"podcast-biotech","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/73180\/podcast-biotech\/","title":{"rendered":"The Munich biotech industry under the microscope"},"content":{"rendered":"<div class=\"entry-content\">\n<figure class=\"wp-block-embed is-type-rich is-provider-spotify wp-block-embed-spotify wp-embed-aspect-21-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"Spotify Embed: Biotech startups from Munich, the VC investor MIG\" style=\"border-radius: 12px\" width=\"100%\" height=\"152\" frameborder=\"0\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; fullscreen; picture-in-picture\" loading=\"lazy\" src=\"https:\/\/open.spotify.com\/embed\/episode\/0pGGK2Vs35fdbXvLJ2KnrO?si=ye604RoYSfyeaDi0UWgypg&#038;utm_source=oembed\"><\/iframe>\n<\/div><\/figure>\n\n\n\n<p>You can find the episode on Biotech and all other episodes of our podcast on&nbsp;<a href=\"https:\/\/open.spotify.com\/show\/2sUcouuLTciRk6USg4AdbF\" target=\"_blank\" rel=\"noreferrer noopener\">Spotify<\/a>,&nbsp;<a href=\"https:\/\/podcasts.apple.com\/de\/podcast\/munich-startup-podcast\/id1519268240\" target=\"_blank\" rel=\"noreferrer noopener\">iTunes<\/a>,&nbsp;<a href=\"https:\/\/www.deezer.com\/de\/show\/1408732\" target=\"_blank\" rel=\"noreferrer noopener\">Deezer<\/a>,&nbsp;<a href=\"https:\/\/www.google.com\/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy8xZWQwMmI3Yy9wb2RjYXN0L3Jzcw==\" target=\"_blank\" rel=\"noreferrer noopener\">Google Podcasts<\/a>,&nbsp;<a href=\"https:\/\/pca.st\/c00hgj2u\" target=\"_blank\" rel=\"noreferrer noopener\">Pocket Casts<\/a>,&nbsp;<a href=\"https:\/\/radiopublic.com\/munich-startup-podcast-6pZlj2\" target=\"_blank\" rel=\"noreferrer noopener\">Radio Public<\/a>, Breaker,&nbsp;<a href=\"https:\/\/overcast.fm\/itunes1519268240\/munich-startup-podcast\" target=\"_blank\" rel=\"noreferrer noopener\">Overcast<\/a>,&nbsp;<a href=\"https:\/\/castbox.fm\/channel\/Munich-Startup-Podcast-id3025621?country=de\" target=\"_blank\" rel=\"noreferrer noopener\">Castbox<\/a>,&nbsp;<a href=\"https:\/\/podcastaddict.com\/podcast\/3042445\" target=\"_blank\" rel=\"noreferrer noopener\">Podcast Addict<\/a>&nbsp;and&nbsp;<a href=\"https:\/\/anchor.fm\/munich-startup\" target=\"_blank\" rel=\"noreferrer noopener\">Anchor<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Munich is the biotech hotspot<\/h2>\n\n\n\n<p>After a few brief announcements, the actual topic of the 23rd Munich Startup Podcast begins at minute 2:10: Biotech. According to the <a href=\"\/en\/73032\/corona-caused-record-investments-in-biotech-in-2020\/\">German Biotechnology Report by EY<\/a> 21 percent of all biotech startups founded last year are based in or around Munich \u2013 a rate that no other region in Germany achieves. For this reason, auditors also describe Munich as a biotech stronghold in Germany. According to our <a href=\"https:\/\/insights.munich-startup.de\/companies.startups\/f\/launch_year_min\/anyof_2009\/regions\/allof_Munich%20Metropolitan%20Area\/sub_industries\/allof_biotechnology\" target=\"_blank\" rel=\"noreferrer noopener\">Munich Startup Insights<\/a> 36 startups and scaleups from the sector.<\/p>\n\n\n\n<p>And things are looking good in terms of financing too: The industry raised a total of \u20ac882 million in venture capital across Germany in 2020. \u20ac560 million of this went to the T\u00fcbingen-based startup Curevac, which is working on a coronavirus vaccine. Of the remainder, however, just under a fifth found its way to Munich: Catalym, among others, secured \u20ac50 million and <a href=\"\/en\/62671\/tubulis-series-a\/\">Tubules<\/a> received 10.7 million euros. A few other startups also received funding, including from EIT Health.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">New medicines thanks to biotech research<\/h2>\n\n\n\n<p>The solutions offered by startups vary greatly. According to the industry association <a href=\"https:\/\/www.biodeutschland.org\/de\/biothek.html?file=files\/content\/medien\/biothek\/BIOD_Broschueren\/Biotech-in-Germany_FactSheet_2020.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Organic Germany<\/a> Around a quarter of all German biotech companies are developing new drugs, such as <a href=\"\/en\/day\/catalym\/\">Catalym<\/a>The Munich-based startup, which we&#039;ll introduce you to starting at minute 3:50, is developing new active ingredients for cancer therapy. The idea, which originated from research at the University of W\u00fcrzburg, has now been further developed to the point of initial clinical trials.<\/p>\n\n\n\n<p>Also suitable for medicines \u2013 but not only \u2013 is the solution of <a href=\"\/en\/day\/4-genes\/\">4Genes<\/a> (from minute 7:45). The company, founded in 2015, has applied basic research at the Technical University of Munich to an application that allows for the targeted release of substances. 4Gene uses this not only to apply fragrances in cosmetics and food on demand, but also to release medicinal substances more specifically in the body.<\/p>\n\n\n\n<p>The next startup, which we will introduce to you in the podcast, also has to do with medicine, but not directly with medication. <a href=\"\/en\/ecosystem\/map\/irubis-gmbh\/\">Irubis<\/a> (from minute 10:50) has not only developed a novel sample carrier for medical analysis \u2013 especially for blood counts. The Munich-based company is also working on a new solution for monitoring bioreactors. With the latter, the startup was able to impress the EU, securing \u20ac1.3 million in funding under the Horizon 2020 funding program.<\/p>\n\n\n\n<p>The startup shows that biotech does not always have to be about medical devices <a href=\"\/en\/day\/amsilk\/\">Amsilk<\/a>The Munich-based company has succeeded in artificially producing spider silk using genetically modified bacteria. The startup plans to use the product, among other things, to develop new lightweight materials with Airbus, but has also collaborated with Adidas in the past. From minute 13:20, you can learn more about Amsilk, the aforementioned interview with the <a href=\"https:\/\/www.laborjournal.de\/editorials\/1208.php\" target=\"_blank\" rel=\"noreferrer noopener\">\u201cLaboratory Journal\u201d<\/a> can be found here.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">An investor for deep tech and life science<\/h2>\n\n\n\n<p>At the end of the podcast we take a look at the venture capital investor <a href=\"\/en\/ecosystem\/map\/mig-verwaltungs-ag\/\">MIG<\/a>The Munich-based investor not only recently invested in Amsilk, but is also known as a founding investor in BioNTech. With its 16 funds, the VC has invested a total of over \u20ac580 million in deep tech and life science startups. A glance at its portfolio reveals numerous well-known Munich-based companies such as Konux, Kewazo, and Navvis.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Munich is Germany&#039;s biotech hotspot: The city is home not only to important networks and financially strong investors, but also to several successful startups. In episode 23 of the Munich Startup Podcast, we take a look at the scene and introduce key players in more detail. <\/p>","protected":false},"author":33,"featured_media":73182,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5638,3971,1083],"tags":[371,2928],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Die M\u00fcnchner Biotech-Branche unter der Lupe - Munich Startup<\/title>\n<meta name=\"description\" content=\"In Folge 23 des Munich Startup Podcasts werfen wir einen Blick auf die M\u00fcnchner Biotech-Szene und stellen wichtige Akteure genauer vor.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/73180\/podcast-biotech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Die M\u00fcnchner Biotech-Branche unter der Lupe - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"In Folge 23 des Munich Startup Podcasts werfen wir einen Blick auf die M\u00fcnchner Biotech-Szene und stellen wichtige Akteure genauer vor.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/73180\/podcast-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-20T10:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-28T11:02:25+00:00\" \/>\n<meta name=\"author\" content=\"Maximilian Feigl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maximilian Feigl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/\",\"url\":\"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/\",\"name\":\"Die M\u00fcnchner Biotech-Branche unter der Lupe - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/05\/analysis-4402809_1920.jpg\",\"datePublished\":\"2021-05-20T10:45:00+00:00\",\"dateModified\":\"2022-02-28T11:02:25+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\"},\"description\":\"In Folge 23 des Munich Startup Podcasts werfen wir einen Blick auf die M\u00fcnchner Biotech-Szene und stellen wichtige Akteure genauer vor.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/05\/analysis-4402809_1920.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/05\/analysis-4402809_1920.jpg\",\"width\":1920,\"height\":1281,\"caption\":\"Biotech\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Die M\u00fcnchner Biotech-Branche unter der Lupe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\",\"name\":\"Maximilian Feigl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"caption\":\"Maximilian Feigl\"},\"description\":\"Maximilian Feigl berichtet seit 2020 \u00fcber das M\u00fcnchner Startup \u00d6kosystem. Dabei haben es dem studierten Politikwissenschaftler vor allem Deeptech-Themen angetan.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2021\/05\/analysis-4402809_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1281\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Munich&#039;s biotech industry under the microscope - Munich Startup","description":"In episode 23 of the Munich Startup Podcast, we take a look at the Munich biotech scene and introduce key players in more detail.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/73180\/podcast-biotech\/","og_locale":"en_US","og_type":"article","og_title":"Die M\u00fcnchner Biotech-Branche unter der Lupe - Munich Startup","og_description":"In Folge 23 des Munich Startup Podcasts werfen wir einen Blick auf die M\u00fcnchner Biotech-Szene und stellen wichtige Akteure genauer vor.","og_url":"https:\/\/cms.munich-startup.net\/en\/73180\/podcast-biotech\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2021-05-20T10:45:00+00:00","article_modified_time":"2022-02-28T11:02:25+00:00","author":"Maximilian Feigl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Maximilian Feigl","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/","url":"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/","name":"Munich&#039;s biotech industry under the microscope - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/05\/analysis-4402809_1920.jpg","datePublished":"2021-05-20T10:45:00+00:00","dateModified":"2022-02-28T11:02:25+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509"},"description":"In episode 23 of the Munich Startup Podcast, we take a look at the Munich biotech scene and introduce key players in more detail.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/05\/analysis-4402809_1920.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/05\/analysis-4402809_1920.jpg","width":1920,"height":1281,"caption":"Biotech"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/73180\/podcast-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Die M\u00fcnchner Biotech-Branche unter der Lupe"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509","name":"Maximilian Feigl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","caption":"Maximilian Feigl"},"description":"Maximilian Feigl has been reporting on the Munich startup ecosystem since 2020. The political scientist is particularly interested in deeptech topics.","url":"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/"}]},"og_image":[{"width":1920,"height":1281,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2021\/05\/analysis-4402809_1920.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1621510829:30","_edit_last":"24","_yoast_wpseo_focuskw":"Biotech","_yoast_wpseo_metadesc":"In Folge 23 des Munich Startup Podcasts werfen wir einen Blick auf die M\u00fcnchner Biotech-Szene und stellen wichtige Akteure genauer vor.","_yoast_wpseo_linkdex":"75","_thumbnail_id":"73182","wbounce_status":"default","_yoast_wpseo_primary_category":"3971","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"60","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"3","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/73180"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=73180"}],"version-history":[{"count":5,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/73180\/revisions"}],"predecessor-version":[{"id":80247,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/73180\/revisions\/80247"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/73182"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=73180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=73180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=73180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}